RANEXA 500 MG

Krajina: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktívna zložka:

RANOLAZINE 500 MG

Dostupné z:

NEOPHARM LTD

ATC kód:

C01EB18

Forma lieku:

TABLETS EXTENDED RELEASE

Spôsob podávania:

PER OS

Výrobca:

CV THERAPEUTICS INC, USA

Terapeutické skupiny:

RANOLAZINE

Terapeutické indikácie:

Ranexa is indicated for the treatment of chronic angina. Ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).Ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.

Dátum Autorizácia:

2010-10-01